tetrakis(dipyridin-4-ylphosphorylimino-hydroxy-dipyridin-4-yl-λ5-phosphane);tetrakis(iridium);2-methyl-5-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]pyrazine;2-methyl-5-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]pyrazine;2-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]-1,3,5-triazine;2-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]-1,3,5-triazine

C124H98F12Ir4N34O8P8-4 — CID 158447854

IUPACtetrakis(dipyridin-4-ylphosphorylimino-hydroxy-dipyridin-4-yl-λ5-phosphane);tetrakis(iridium);2-methyl-5-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]pyrazine;2-methyl-5-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]pyrazine;2-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]-1,3,5-triazine;2-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]-1,3,5-triazine
SMILESCc1cc(-c2ncncn2)[c-]c(C(F)(F)F)n1.Cc1cnc(-c2[c-]c(C(F)(F)F)nc(C)c2)cn1.Cc1cnc(-c2[c-]cc(C(F)(F)F)nc2C)cn1.Cc1nc(C(F)(F)F)c[c-]c1-c1ncncn1.O=P(N=P(O)(c1ccncc1)c1ccncc1)(c1ccncc1)c1ccncc1.O=P(N=P(O)(c1ccncc1)c1ccncc1)(c1ccncc1)c1ccncc1.O=P(N=P(O)(c1ccncc1)c1ccncc1)(c1ccncc1)c1ccncc1.O=P(N=P(O)(c1ccncc1)c1ccncc1)(c1ccncc1)c1ccncc1.[Ir].[Ir].[Ir].[Ir]
InChIInChI=1S/4C20H17N5O2P2.2C12H9F3N3.2C10H6F3N4.4Ir/c4*26-28(17-1-9-21-10-2-17,18-3-11-22-12-4-18)25-29(27,19-5-13-23-14-6-19)20-7-15-24-16-8-20;1-7-3-9(4-11(18-7)12(13,14)15)10-6-16-8(2)5-17-10;1-7-5-17-10(6-16-7)9-3-4-11(12(13,14)15)18-8(9)2;1-6-2-7(9-15-4-14-5-16-9)3-8(17-6)10(11,12)13;1-6-7(9-15-4-14-5-16-9)2-3-8(17-6)10(11,12)13;;;;/h4*1-16,26H;3,5-6H,1-2H3;4-6H,1-2H3;2,4-5H,1H3;3-5H,1H3;;;;/q;;;;4*-1;;;;
InChIKeyWIJKKMDOMGDOSB-UHFFFAOYSA-N
MW3437.01 g/mol
LogP19.08
Rot. Bonds24

About tetrakis(dipyridin-4-ylphosphorylimino-hydroxy-dipyridin-4-yl-λ5-phosphane);tetrakis(iridium);2-methyl-5-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]pyrazine;2-methyl-5-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]pyrazine;2-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]-1,3,5-triazine;2-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]-1,3,5-triazine

tetrakis(dipyridin-4-ylphosphorylimino-hydroxy-dipyridin-4-yl-λ5-phosphane);tetrakis(iridium);2-methyl-5-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]pyrazine;2-methyl-5-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]pyrazine;2-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]-1,3,5-triazine;2-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]-1,3,5-triazine (PubChem CID 158447854) has the molecular formula C124H98F12Ir4N34O8P8-4 and a molecular weight of 3437.01 g/mol. Its IUPAC name is tetrakis(dipyridin-4-ylphosphorylimino-hydroxy-dipyridin-4-yl-λ5-phosphane);tetrakis(iridium);2-methyl-5-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]pyrazine;2-methyl-5-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]pyrazine;2-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]-1,3,5-triazine;2-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]-1,3,5-triazine.

Molecular Properties

Compound Nametetrakis(dipyridin-4-ylphosphorylimino-hydroxy-dipyridin-4-yl-λ5-phosphane);tetrakis(iridium);2-methyl-5-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]pyrazine;2-methyl-5-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]pyrazine;2-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]-1,3,5-triazine;2-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]-1,3,5-triazine
PubChem CID158447854
Molecular FormulaC124H98F12Ir4N34O8P8-4
Molecular Weight3437.01 g/mol
Exact Mass3438.46
IUPAC Nametetrakis(dipyridin-4-ylphosphorylimino-hydroxy-dipyridin-4-yl-λ5-phosphane);tetrakis(iridium);2-methyl-5-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]pyrazine;2-methyl-5-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]pyrazine;2-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]-1,3,5-triazine;2-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]-1,3,5-triazine
SMILESCc1cc(-c2ncncn2)[c-]c(C(F)(F)F)n1.Cc1cnc(-c2[c-]c(C(F)(F)F)nc(C)c2)cn1.Cc1cnc(-c2[c-]cc(C(F)(F)F)nc2C)cn1.Cc1nc(C(F)(F)F)c[c-]c1-c1ncncn1.O=P(N=P(O)(c1ccncc1)c1ccncc1)(c1ccncc1)c1ccncc1.O=P(N=P(O)(c1ccncc1)c1ccncc1)(c1ccncc1)c1ccncc1.O=P(N=P(O)(c1ccncc1)c1ccncc1)(c1ccncc1)c1ccncc1.O=P(N=P(O)(c1ccncc1)c1ccncc1)(c1ccncc1)c1ccncc1.[Ir].[Ir].[Ir].[Ir]
InChIInChI=1S/4C20H17N5O2P2.2C12H9F3N3.2C10H6F3N4.4Ir/c4*26-28(17-1-9-21-10-2-17,18-3-11-22-12-4-18)25-29(27,19-5-13-23-14-6-19)20-7-15-24-16-8-20;1-7-3-9(4-11(18-7)12(13,14)15)10-6-16-8(2)5-17-10;1-7-5-17-10(6-16-7)9-3-4-11(12(13,14)15)18-8(9)2;1-6-2-7(9-15-4-14-5-16-9)3-8(17-6)10(11,12)13;1-6-7(9-15-4-14-5-16-9)2-3-8(17-6)10(11,12)13;;;;/h4*1-16,26H;3,5-6H,1-2H3;4-6H,1-2H3;2,4-5H,1H3;3-5H,1H3;;;;/q;;;;4*-1;;;;
InChIKeyWIJKKMDOMGDOSB-UHFFFAOYSA-N
XLogP19.08
TPSA585.34 Ų
H-Bond Donors4
H-Bond Acceptors34
Rotatable Bonds24
Heavy Atoms190
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003437.01
LogP ≤ 519.08
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1034

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze tetrakis(dipyridin-4-ylphosphorylimino-hydroxy-dipyridin-4-yl-λ5-phosphane);tetrakis(iridium);2-methyl-5-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]pyrazine;2-methyl-5-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]pyrazine;2-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]-1,3,5-triazine;2-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]-1,3,5-triazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tetrakis(dipyridin-4-ylphosphorylimino-hydroxy-dipyridin-4-yl-λ5-phosphane);tetrakis(iridium);2-methyl-5-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]pyrazine;2-methyl-5-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]pyrazine;2-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]-1,3,5-triazine;2-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]-1,3,5-triazine?
The IUPAC name of tetrakis(dipyridin-4-ylphosphorylimino-hydroxy-dipyridin-4-yl-λ5-phosphane);tetrakis(iridium);2-methyl-5-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]pyrazine;2-methyl-5-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]pyrazine;2-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]-1,3,5-triazine;2-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]-1,3,5-triazine (CID 158447854) is tetrakis(dipyridin-4-ylphosphorylimino-hydroxy-dipyridin-4-yl-λ5-phosphane);tetrakis(iridium);2-methyl-5-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]pyrazine;2-methyl-5-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]pyrazine;2-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]-1,3,5-triazine;2-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]-1,3,5-triazine.
What is the SMILES notation for tetrakis(dipyridin-4-ylphosphorylimino-hydroxy-dipyridin-4-yl-λ5-phosphane);tetrakis(iridium);2-methyl-5-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]pyrazine;2-methyl-5-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]pyrazine;2-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]-1,3,5-triazine;2-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]-1,3,5-triazine?
The canonical SMILES for tetrakis(dipyridin-4-ylphosphorylimino-hydroxy-dipyridin-4-yl-λ5-phosphane);tetrakis(iridium);2-methyl-5-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]pyrazine;2-methyl-5-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]pyrazine;2-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]-1,3,5-triazine;2-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]-1,3,5-triazine is Cc1cc(-c2ncncn2)[c-]c(C(F)(F)F)n1.Cc1cnc(-c2[c-]c(C(F)(F)F)nc(C)c2)cn1.Cc1cnc(-c2[c-]cc(C(F)(F)F)nc2C)cn1.Cc1nc(C(F)(F)F)c[c-]c1-c1ncncn1.O=P(N=P(O)(c1ccncc1)c1ccncc1)(c1ccncc1)c1ccncc1.O=P(N=P(O)(c1ccncc1)c1ccncc1)(c1ccncc1)c1ccncc1.O=P(N=P(O)(c1ccncc1)c1ccncc1)(c1ccncc1)c1ccncc1.O=P(N=P(O)(c1ccncc1)c1ccncc1)(c1ccncc1)c1ccncc1.[Ir].[Ir].[Ir].[Ir].
What is the InChIKey of tetrakis(dipyridin-4-ylphosphorylimino-hydroxy-dipyridin-4-yl-λ5-phosphane);tetrakis(iridium);2-methyl-5-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]pyrazine;2-methyl-5-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]pyrazine;2-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]-1,3,5-triazine;2-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]-1,3,5-triazine?
The InChIKey is WIJKKMDOMGDOSB-UHFFFAOYSA-N. The full InChI is InChI=1S/4C20H17N5O2P2.2C12H9F3N3.2C10H6F3N4.4Ir/c4*26-28(17-1-9-21-10-2-17,18-3-11-22-12-4-18)25-29(27,19-5-13-23-14-6-19)20-7-15-24-16-8-20;1-7-3-9(4-11(18-7)12(13,14)15)10-6-16-8(2)5-17-10;1-7-5-17-10(6-16-7)9-3-4-11(12(13,14)15)18-8(9)2;1-6-2-7(9-15-4-14-5-16-9)3-8(17-6)10(11,12)13;1-6-7(9-15-4-14-5-16-9)2-3-8(17-6)10(11,12)13;;;;/h4*1-16,26H;3,5-6H,1-2H3;4-6H,1-2H3;2,4-5H,1H3;3-5H,1H3;;;;/q;;;;4*-1;;;;.
What are the key properties of tetrakis(dipyridin-4-ylphosphorylimino-hydroxy-dipyridin-4-yl-λ5-phosphane);tetrakis(iridium);2-methyl-5-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]pyrazine;2-methyl-5-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]pyrazine;2-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]-1,3,5-triazine;2-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]-1,3,5-triazine?
tetrakis(dipyridin-4-ylphosphorylimino-hydroxy-dipyridin-4-yl-λ5-phosphane);tetrakis(iridium);2-methyl-5-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]pyrazine;2-methyl-5-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]pyrazine;2-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]-1,3,5-triazine;2-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]-1,3,5-triazine has a molecular weight of 3437.01 g/mol, XLogP of 19.08, 24 rotatable bonds, 4 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for tetrakis(dipyridin-4-ylphosphorylimino-hydroxy-dipyridin-4-yl-λ5-phosphane);tetrakis(iridium);2-methyl-5-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]pyrazine;2-methyl-5-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]pyrazine;2-[2-methyl-6-(trifluoromethyl)-4H-pyridin-4-id-3-yl]-1,3,5-triazine;2-[6-methyl-2-(trifluoromethyl)-3H-pyridin-3-id-4-yl]-1,3,5-triazine is sourced from PubChem (CID 158447854), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).